ACC

NEW YORK (GenomeWeb) — Despite sustained interest among researchers and diagnostics developers in advancing molecular tests to personalize cardiovascular care, integration of such tools into clinical practice is happening slowly where at all.

The company will work with the American College of Cardiology to create a clinical resource on the web for peer-reviewed biomarker information.

Research presented at the American College of Cardiology scientific session in Atlanta today suggests individuals who receive genetic testing early in their warfarin treatment are up to 31 percent less likely to be hospitalized than those who don't.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.